Providing cost-effective therapy using pharmacoeconomic evaluations: The public sector approach

Clinical Therapeutics

Volumn 19, Issue 1, 1997, Pages 160-166

  Finder, Steven ^a  

^a MedAnalysis   (United States)

Author keywords

cost control; cost effectiveness; formulary management; health economics; pharmacoeconomics

Indexed keywords

CLINICAL TRIAL; CONFERENCE PAPER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; DRUG COST; DRUG FORMULARY; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MILITARY MEDICINE; PATIENT CARE; PHARMACOECONOMICS; PHARMACY; TECHNIQUE;

EID: 0030894781     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80083-5     Document Type: Conference Paper

References (8)

1. Lewis NJ, Patwell JT, Briesacher BA. The role of insurance claims databases in drug therapy outcomes research. Pharmaco-Economics. 1993;4:323-330.
2. Bootman JL, Townsend RJ, McGhan WF. Principles of Pharmacoeconomics. Cincinnati, Oh: Harvey Whitney Books Company; 1991.
3. Carrin G. Economic evaluation of health care interventions: A review of alternative methods. Soc Sci Med. 1984;19:1015-1030.
4. Warren TA, Finder SF, Brier KL, et al. A cost-effective analysis of typhoid fever vaccines in US military personnel. PharmacoEconomics. 1996;10:475-483.
5. Freund D, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. PharmucoEconomics. 1992;1:20-32.
6. Kaplan NM. Pitfalls in the interpretation of pharmacoeconomic studies. PharmacoEconomics. 1992;1:303-305.
7. Davey P, Malek M. The impact of pharmacoeconomics on the practitioner and the patient. A conflict of interests? PharmacoEconomics. 1994;6:298-309.
8. Weinstein MC, Stason WB. Foundations of cost-effective analysis for health and medical practice. NEJM. 1977;296: 716-727.